Influenza-binding antibodies immobilise influenza viruses in fresh human airway mucus

European Respiratory Journal

Volumn 49, Issue 1, 2017, Pages

  Wang, Ying Ying ^a   Harit, Dimple ^b   Subramani, Durai B ^b   Arora, Harendra ^c   Kumar, Priya A ^c   Lai, Samuel K ^b,c,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNC Hamner Institute for Drug Safety Sciences   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d Biomedical Research Imaging Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; MUCIN; FLUORESCENT DYE; HEMAGGLUTININ; MACROGOL; NANOPARTICLE; VIRUS ANTIBODY;

AIRWAY MUCUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); LETTER; MUCUS; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SEASONAL INFLUENZA; VIRION; VIRUS LIKE AGENT; VIRUS STRAIN; CHEMISTRY; EPIDEMIC; IMMUNOLOGY; INFLUENZA; MOTION; PARTICLE SIZE; RESPIRATORY SYSTEM; VIROLOGY;

ANTIBODIES, VIRAL; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT DYES; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MOTION; MUCUS; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RESPIRATORY SYSTEM; VIRION;

EID: 85031020633     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01709-2016     Document Type: Letter

References (19)

1. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med 2010; 363: 2233–2247.
2. Lai SK, Hida K, Shukair S, et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 2009; 83: 11196–11200.
3. Olmsted SS, Padgett JL, Yudin AI, et al. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J 2001; 81: 1930–1937.
4. Wang YY, Kannan A, Nunn KL, et al. IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections. Mucosal Immunol 2014; 7: 1036–1044.
5. Schuster BS, Suk JS, Woodworth GF, et al. Nanoparticle diffusion in respiratory mucus from humans without lung disease. Biomaterials 2013; 34: 3439–3446.
6. Lai SK, Wang YY, Hida K, et al. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci USA 2010; 107: 598–603.
7. Schuster BS, Kim AJ, Kays JC, et al. Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors. Mol Ther 2014; 22: 1484–1493.
8. Wang YY, Nunn KL, Harit D, et al. Minimizing biases associated with tracking analysis of submicron particles in heterogeneous biological fluids. J Control Release 2015; 220: 37–43.
9. Lai SK, O’Hanlon DE, Harrold S, et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci USA 2007; 104: 1482–1487.
10. Wang YY, Lai SK, Suk JS, et al. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that “slip” through the human mucus barrier. Angew Chem Int Ed Engl 2008; 47: 9726–9729.
11. Steel J, Lowen AC, Wang TT, et al. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 2010; 1: 00018-10.
12. Gagneux P, Cheriyan M, Hurtado-Ziola N, et al. Human-specific regulation of α2-6-linked sialic acids. J Biol Chem 2003; 278: 48245–48250.
13. Matrosovich M, Klenk HD. Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding. Rev Med Virol 2003; 13: 85–97.
14. Nicoll A, Sprenger M. Low effectiveness undermines promotion of seasonal influenza vaccine. Lancet Infect Dis 2013; 13: 7–9.
15. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361: 2209–2220.
16. Lakdawala SS, Jayaraman A, Halpin RA, et al. The soft palate is an important site of adaptation for transmissible influenza viruses. Nature 2015; 526: 122–125.
17. Roberts KL, Manicassamy B, Lamb RA. Influenza A virus uses intercellular connections to spread to neighboring cells. J Virol 2015; 89: 1537–1549.
18. Chowell G, Miller MA, Viboud C. Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiol Infect 2008; 136: 852–864.
19. Chunara R, Goldstein E, Patterson-Lomba O, et al. Estimating influenza attack rates in the United States using a participatory cohort. Sci Rep 2015; 5: 9540.